Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Felgner

Showing results (101-110 of 269) with videos related to

Pageof 27
Sort By:
Plos Computational Biology|June 7, 2024
Machine learning prediction of malaria vaccine efficacy based on antibody profilesJacqueline Wistuba-Hamprecht, Bernhard Reuter, Rolf Fendel, et al.
Molecular & Cellular Proteomics : MCP|June 2, 2011
Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigensAngela Trieu, Matthew A Kayala, Chad Burk, et al.
Proteomics|April 15, 2010
Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarrayAdam Vigil, Rocio Ortega, Rie Nakajima-Sasaki, et al.
The Journal of Infectious Diseases|October 15, 2011
Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigensXiaolin Tan, Boubacar Traore, Kassoum Kayentao, et al.
Gene Therapy|January 1, 1995
Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epitheliumJ J Logan, Z Bebok, L C Walker, et al.
Journal of Immunological Methods|June 13, 2009
ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humansLichen Jing, Stella Mayo McCaughey, D Huw Davies, et al.
Journal of Virology|September 6, 2005
Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in miceD Huw Davies, Megan M McCausland, Conrad Valdez, et al.
Vaccine|November 22, 2011
Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAsGary Hermanson, Sookhee Chun, Jiin Felgner, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected miceK Y Hostetler, D D Richman, C N Sridhar, et al.
Scientific Reports|December 20, 2013
Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxisPhilip L Felgner, Meta Roestenberg, Li Liang, et al.
Pageof 27

Showing results (101-110 of 269) with videos related to

Sort By:
Pageof 27
Plos Computational Biology|June 7, 2024
Machine learning prediction of malaria vaccine efficacy based on antibody profilesJacqueline Wistuba-Hamprecht, Bernhard Reuter, Rolf Fendel, et al.
Molecular & Cellular Proteomics : MCP|June 2, 2011
Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigensAngela Trieu, Matthew A Kayala, Chad Burk, et al.
Proteomics|April 15, 2010
Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarrayAdam Vigil, Rocio Ortega, Rie Nakajima-Sasaki, et al.
The Journal of Infectious Diseases|October 15, 2011
Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigensXiaolin Tan, Boubacar Traore, Kassoum Kayentao, et al.
Gene Therapy|January 1, 1995
Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epitheliumJ J Logan, Z Bebok, L C Walker, et al.
Journal of Immunological Methods|June 13, 2009
ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humansLichen Jing, Stella Mayo McCaughey, D Huw Davies, et al.
Journal of Virology|September 6, 2005
Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in miceD Huw Davies, Megan M McCausland, Conrad Valdez, et al.
Vaccine|November 22, 2011
Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAsGary Hermanson, Sookhee Chun, Jiin Felgner, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected miceK Y Hostetler, D D Richman, C N Sridhar, et al.
Scientific Reports|December 20, 2013
Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxisPhilip L Felgner, Meta Roestenberg, Li Liang, et al.
Pageof 27